SUSAN SHOWS US. >> THEYRE A TOTAL, COMPLETE FAMILY DOGS. >> HE’S A FAMILY FRIENDLY ENGLISH SETTER, BUT THE EIGHT-YEAR-OLD HAS HAD A TOUGH TIME GETTING AROUND. >> YOU SEE THIS POOR DOG LIMPING SO BAD ...

Many of us are far too familiar with the term “arthritis.” Well, so are many of our dogs. The arthritis most of our dogs get is known as osteoarthritis, or OA. It is a challenging disease involving ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injection) for the control of pain ...

Company Remains Confident in the Safety and Effectiveness of Librela and Reaffirms Its Commitment to Supporting Veterinarians and Pet Owners in Helping Dogs with OA Live with Less Pain and Greater ...

Osteoarthritis is a common, chronic and progressive joint disease characterized by the inflammation and breakdown of joints, leading to pain and mobility issues. Although the disease cannot be cured, ...

17 client-owned dogs with radiographically confirmed OA received 1 mg intramuscular ElenaVet™ once a week for 10 weeks. Pain Severity Score (PSS) fell from 5.25 → 3.25 and Pain Interference Score (PIS ...

Osteoarthritis (OA) is a leading cause of chronic pain and mobility loss in older dogs. Management is “multimodal,” combining pharmaceuticals, weight control, and physical therapy. Non-steroidal ...

PARSIPPANY, N.J., October 10, 2025--(BUSINESS WIRE)--Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a ...

Canine OA is a painful and progressive disease that is highly prevalent. In studies, 40% of dogs have signs of OA. 3,4 With an estimated 86 million dogs living in the U.S. households, a high ...

First long-acting canine anti-nerve growth factor monoclonal antibody therapy administered once every three months Approval marks major milestone in the company’s continued innovation for canine OA ...

Zoetis Inc. today announced that Health Canada has approved Lenivia ® (izenivetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in dogs. Built on a decade of science and ...